BioStar gains distribution of chlamydia test:
This article was originally published in Clinica
Executive Summary
General Injectables and Vaccines has added BioStar's Chlamydia Optical ImmunoAssay point-of-care test to the antibiotic Zithromax which it is already distributing for Pfizer. General Injectables agreed a joint marketing deal with BioStar, a privately-held company in Boulder, Colorado, which specialises in developing point-of-care tests for infectious diseases.